Results 71 to 80 of about 15,641 (133)

Testosterone Replacement in Prostate Carcinoma: A Systematic Review of an Emerging Paradigm and Therapeutic Potential. [PDF]

Cureus
Robinson J, Banerjee I, Banerjee I.
europepmc   +1 more source

Mapping prostate cancer pathobiology: A review of genetically engineered mouse models (GEMMs). [PDF]

Gene
Pederzoli F, Pakula H, Rodrigues S, Garner R, Nuzzo PV, Bleve S, Rickman DS, Fanelli GN, Loda M.   +8 more
europepmc   +1 more source

Survival after spinal surgery for metastases in men with castration-sensitive vs castration-resistant prostate cancer: a nationwide register-based study. [PDF]

Sci Rep
Wänman J, Farhang M, Nyström H, Styrke J, Häggström C, Stattin P, Crnalic S.   +6 more
europepmc   +1 more source

IL-6/STAT3 signaling in prostate cancer: CAF-driven immune evasion and therapeutic opportunities. [PDF]

Front Immunol
Zhou T, Li Y, Liu Z, Zeng Z, Li T, Chen L, Zhao H, Wu X, Shen Y, Fan H, Zhu X, Zhou Y, Zou L, Zhao D.   +13 more
europepmc   +1 more source

Quantitative PSMA PET Biomarkers for Predicting Response to ¹⁷⁷Lu-PSMA Therapy in Prostate Cancer: A Systematic Review and Meta-analysis. [PDF]

J Nucl Med
Kiani I, Siri MA, Babaei M, Aliasghari MM, Mohammadzadeh S, Mohammadi S, Salavati A.   +6 more
europepmc   +1 more source

Paradoxical Effect of Obesity on Survival Outcomes in Prostate Cancer Patients Receiving Enzalutamide and Abiraterone. [PDF]

Medicina (Kaunas)
Kaya BE, Koçak MZ, Yıldız O, Aykut T, Gürbüz AF, Genç Ö, Karakurt Eryılmaz M, Araz M, Artaç M.   +8 more
europepmc   +1 more source

Prognostic Value of Cycle 1 SPECT SUV_mean in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with ¹⁷⁷Lu-PSMA-617. [PDF]

J Nucl Med
Ghodsi A, Demirci RA, Gulati R, Nelson PS, Raychaudhuri R, Cheng HH, Sunkara R, Khan H, Rios RN, Hsieh A, Grivas P, Montgomery B, Yezefski TA, Yu EY, Schweizer MT, Chen DL, Iravani A.   +16 more
europepmc   +1 more source

Prognostic Factors of Castration-Resistant Prostate Cancer Among Patients With Localized Prostate Cancer Who Underwent Robot-Assisted Radical Prostatectomy in a Retrospective Multicenter Japanese Cohort (MSUG94). [PDF]

Int J Urol
Sasaki T, Igarashi A, Ebara S, Tatenuma T, Ikehata Y, Nakayama A, Kawase M, Toide M, Yoneda T, Sakaguchi K, Teishima J, Makiyama K, Kitamura H, Saito K, Koie T, Koga F, Urakami S, Yamasaki T, Inoue T.   +18 more
europepmc   +1 more source

Phase 2 trial of pTVG-HP ± pTVG-AR DNA vaccines and pembrolizumab in patients with metastatic, castration-resistant prostate cancer (mCRPC). [PDF]

J Immunother Cancer
Kyriakopoulos CE, Pachynski RK, Eickhoff JC, Tonelli TP, Jeon D, McNeel DG.   +5 more
europepmc   +1 more source

Two Cases of Metastatic Castration-Resistant Prostate Cancer With Long-Term Survival Treated With Abiraterone. [PDF]

Clin Case Rep
Une M, Yamamoto S, Fuse H, Fujiwara R, Yonese J, Noda K.   +5 more
europepmc   +1 more source